Clinical Trials in Austin

Showing 9641-9660 of 11,561 trials

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

NCT01776541

Evaluate Safety, Tolerability and Immune Response of Adjuvanted H5N1 Cell Culture Derived Influenza Vaccine in Adult Subjects.

Pandemic H5N1 Influenza

Novartis Vaccines979 participantsStarted Jan 2013

Miami, Florida, United States • St Louis, Missouri, United States • St Louis, Missouri, United States +5 more locations

COMPLETEDPhase 317 miles

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

NCT00451451

To determine if treatment with BG00012 can decrease the number of MS relapses during a certain time period. Other goals of the study are to determine if, over time, BG00012 treatment can decrease the number of certain types of brain lesions commonly seen in MS patients and slow down the time it takes for MS to get worse. Other objectives of the study are to determine the safety and tolerability of BG00012, as well as the effect it may have on tests and evaluations used to assess MS. Additionally, glatiramer acetate is being used to compare its benefits and risks with placebo and BG00012.

Relapsing-Remitting Multiple Sclerosis

Biogen1,417 participantsStarted Jun 2007

Birmingham, Alabama, United States • Cullman, Alabama, United States • Huntsville, Alabama, United States +192 more locations

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

Find Trials by Condition in Austin

hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery

NAVISTAR® THERMOCOOL® SF Catheter: Observational Study

Study of Oasis Ultra in Diabetic Foot Ulcers

Aneurysm Study of Pipeline in an Observational Registry

A Postmarket Randomized Study of the Treatment of Superficial Partial-Thickness Burns Using Two Dressings

Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Tibial Delayed Healing Pivotal Clinical Trial

Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients